{"id":"https://openalex.org/W4362624641","doi":"https://doi.org/10.1158/1535-7163.22521165.v1","title":"Figure S3 from Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma","display_name":"Figure S3 from Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362624641","doi":"https://doi.org/10.1158/1535-7163.22521165.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22521165.v1","doi":"https://doi.org/10.1158/1535-7163.22521165.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22521165.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S3_from_Circulating_Tumor_Cells_and_Biomarker_Modulation_with_Olaratumab_Monotherapy_Followed_by_Olaratumab_plus_Doxorubicin_Phase_Ib_Study_in_Patients_with_Soft-Tissue_Sarcoma/22521165/1/files/39983808.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S3_from_Circulating_Tumor_Cells_and_Biomarker_Modulation_with_Olaratumab_Monotherapy_Followed_by_Olaratumab_plus_Doxorubicin_Phase_Ib_Study_in_Patients_with_Soft-Tissue_Sarcoma/22521165/1/files/39983808.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023576532","display_name":"Javier Mart\u00edn\u2010Broto","orcid":"https://orcid.org/0000-0001-7350-6916","observed_orcids":["https://orcid.org/0000-0001-7350-6916"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Javier Mart\u00edn-Broto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7350-6916","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085410610","display_name":"Antonio Lopez Pousa","orcid":"https://orcid.org/0000-0003-1066-3951","observed_orcids":["https://orcid.org/0000-0003-1066-3951"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonio L\u00f3pez Pousa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034066580","display_name":"Andrew Scott Brohl","orcid":"https://orcid.org/0000-0002-0071-0534","observed_orcids":["https://orcid.org/0000-0002-0071-0534"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew S. Brohl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003432789","display_name":"Brian Andrew Van Tine","orcid":"https://orcid.org/0000-0003-4572-6668","observed_orcids":["https://orcid.org/0000-0003-4572-6668"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian A. Van Tine","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4572-6668","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091789927","display_name":"Benjamin Powers","orcid":"https://orcid.org/0000-0002-9406-8916","observed_orcids":["https://orcid.org/0000-0002-9406-8916"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Powers","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9406-8916","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060954086","display_name":"Silvia Stacchiotti","orcid":"https://orcid.org/0000-0002-1742-8666","observed_orcids":["https://orcid.org/0000-0002-1742-8666"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvia Stacchiotti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042202815","display_name":"Jean\u2010Yves Blay","orcid":"https://orcid.org/0000-0001-7190-120X","observed_orcids":["https://orcid.org/0000-0001-7190-120X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Yves Blay","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7190-120X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029708659","display_name":"James S. Hu","orcid":"https://orcid.org/0000-0003-0620-4664","observed_orcids":["https://orcid.org/0000-0003-0620-4664"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James S. Hu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023660150","display_name":"Gerard J. Oakley","orcid":"https://orcid.org/0000-0002-2345-9629","observed_orcids":["https://orcid.org/0000-0002-2345-9629"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerard J. Oakley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100370875","display_name":"Hong Wang","orcid":"https://orcid.org/0000-0001-8098-4473","observed_orcids":["https://orcid.org/0000-0001-8098-4473"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hong Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043218456","display_name":"Anna M. Szpurka","orcid":"https://orcid.org/0000-0002-1348-955X","observed_orcids":["https://orcid.org/0000-0002-1348-955X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna M. Szpurka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103472062","display_name":"Donna Elise Levy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donna E. Levy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027133543","display_name":"Gary C. H. Mo","orcid":"https://orcid.org/0000-0002-3191-2155","observed_orcids":["https://orcid.org/0000-0002-3191-2155"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary Mo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075536764","display_name":"Matteo Ceccarelli","orcid":"https://orcid.org/0009-0000-6780-3957","observed_orcids":["https://orcid.org/0009-0000-6780-3957"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matteo Ceccarelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5048969933","display_name":"Robin L. Jones","orcid":"https://orcid.org/0000-0003-4173-3844","observed_orcids":["https://orcid.org/0000-0003-4173-3844"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robin L. Jones","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4173-3844","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.9950000047683716},{"id":"https://openalex.org/keywords/olaratumab","display_name":"olaratumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/soft-tissue-sarcoma","display_name":"soft tissue sarcoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ctc-enumeration","display_name":"CTC enumeration","score":0.7279999852180481},{"id":"https://openalex.org/keywords/best-overall-response","display_name":"best overall response","score":0.8790000081062317},{"id":"https://openalex.org/keywords/biomarker-modulation","display_name":"biomarker modulation","score":0.6980000138282776}],"concepts":[{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.729049026966095},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.5942751169204712},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5635473132133484},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.5001754760742188},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47656750679016113},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43316149711608887},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41031455993652344},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1718868613243103},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.14716416597366333}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.22521165.v1","doi":"https://doi.org/10.1158/1535-7163.22521165.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22521165.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S3_from_Circulating_Tumor_Cells_and_Biomarker_Modulation_with_Olaratumab_Monotherapy_Followed_by_Olaratumab_plus_Doxorubicin_Phase_Ib_Study_in_Patients_with_Soft-Tissue_Sarcoma/22521165/1/files/39983808.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22521165","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Figure_S3_from_Circulating_Tumor_Cells_and_Biomarker_Modulation_with_Olaratumab_Monotherapy_Followed_by_Olaratumab_plus_Doxorubicin_Phase_Ib_Study_in_Patients_with_Soft-Tissue_Sarcoma/22521165","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22521165.v1","doi":"https://doi.org/10.1158/1535-7163.22521165.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22521165.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S3_from_Circulating_Tumor_Cells_and_Biomarker_Modulation_with_Olaratumab_Monotherapy_Followed_by_Olaratumab_plus_Doxorubicin_Phase_Ib_Study_in_Patients_with_Soft-Tissue_Sarcoma/22521165/1/files/39983808.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362624641.pdf","grobid_xml":"https://content.openalex.org/works/W4362624641.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362614451","https://openalex.org/W7207937021","https://openalex.org/W4362624677","https://openalex.org/W3099532307","https://openalex.org/W4362637733","https://openalex.org/W4392689823","https://openalex.org/W4362624546","https://openalex.org/W4251437602","https://openalex.org/W2936663950","https://openalex.org/W2972069847"],"abstract_inverted_index":{"CTC":[0],"enumeration":[1],"patterns":[2],"in":[3],"all":[4],"population":[5],"CTCs":[6],"by":[7],"best":[8],"overall":[9],"response":[10],"rate.":[11]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2023-04-07T00:00:00"}